| 1 |
Gilbert M. Wolrich |
Intel |
270 |
| 2 |
Richard J. Paolini, Jr. |
Nuclera |
165 |
| 3 |
Pieter J. Mosterman |
The Mathworks |
133 |
| #4 |
Hilmar Lehnert |
Sonos |
79 |
| #5 |
Steven J. Frank |
Ultrata |
73 |
| #6 |
Paul S. Charifson |
Vertex Pharmaceuticals Incorporated |
66 |
| #7 |
Romesh R. Subramanian |
Dyne Therapeutics |
65 |
| #8 |
Marvin L. Vestal |
Virgin Instruments |
63 |
| #9 |
Garth A. Dickie |
IBM |
62 |
| #10 |
Lynn Doucette-Stamm |
Sanofi Pasteur |
59 |
| #11 |
Michael Louis Miller |
Immunogen |
56 |
| #12 |
Adi Ofer |
Emc |
55 |
| #13 |
Donald E. Chickering, III |
Acusphere |
53 |
| #14 |
Julius F. Remenar |
Alkermes Pharma Ireland Limited |
52 |
| #15 |
Martin W. Rupich |
American Superconductor |
43 |
| #15 |
Kristopher William Schulz |
The Gillette Company |
43 |
| #17 |
Vijay Raghavan |
The Mathworks |
41 |
| #17 |
Douglas A. Voorhies |
NVIDIA |
41 |
| #17 |
Steven J. Blacker |
Corindus |
41 |
| #20 |
Jennifer H. Czerepinski |
Saint-Gobain Ceramics & Plastics |
39 |
| #20 |
Daniel Castel |
Emc |
39 |
| #22 |
George E. Hartwell |
The Dow Chemical |
36 |
| #22 |
Michael Cooperman |
Gte Laboratories Incorporated |
36 |
| #24 |
Daniel M. Fogarty |
Hunter Douglas |
35 |
| #24 |
John T. Foreman |
Q2100 |
35 |
| #24 |
John A. Hingston |
Boston Scientific Scimed |
35 |
| #27 |
John H. Jones |
The Institute For Pharmaceutical Discovery |
34 |
| #27 |
Moshe Yanai |
Emc |
34 |
| #29 |
Jinwang Xu |
Vertex Pharmaceuticals Incorporated |
33 |
| #29 |
Lakshmi Bhagat |
Idera Pharmaceuticals |
33 |
| #29 |
Gustavo Fontana |
Bose |
33 |
| #32 |
Ronald Kelley |
Motorola |
32 |
| #32 |
Abraham Scaria |
Genzyme |
32 |
| #32 |
Brett Haarala |
Covidien Lp |
32 |
| #32 |
Bryce A. Harrison |
Morphic Therapeutic |
32 |
| #36 |
Rachit Ohri |
Covidien Lp |
31 |
| #37 |
Albert R. LeBoeuf |
Alcon Laboratories |
30 |
| #37 |
Petros Kotidis |
Axsun Technologies |
30 |
| #37 |
Guoyou Xu |
Enanta Pharmaceuticals |
30 |
| #40 |
Carl F. Buhrer |
Gte Laboratories Incorporated |
29 |
| #40 |
Michael M. Lipp |
Civitas Therapeutics |
29 |
| #42 |
Raymond Avitable |
Covidien Lp |
28 |
| #42 |
Hana Moreshet |
Emc |
28 |
| #42 |
Socheavy D. Heng |
Emc Ip Holding Company |
28 |
| #45 |
Per Onnerud |
Boston-Power |
27 |
| #45 |
David J. Calderwood |
Abbott |
27 |
| #45 |
Thomas Gaudette |
The Mathworks |
27 |
| #48 |
Xiangyun Ye |
Cognex |
25 |
| #48 |
Carol Iturralde |
Cisco |
25 |
| #48 |
Charles Barker |
Aurora Networks |
25 |